Join
Live feed
·
INSIDERFilingvia Quantisnow
Inhibrx Biosciences Inc. logo

Director Vuori Kristiina Md bought $99,992 worth of shares (6,636 units at $15.07), increasing direct ownership by 93% to 13,776 units (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track INBX (Inhibrx Biosciences Inc.) and more on Quantisnow.